Amneal Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Amneal Pharmaceuticals, Inc.

Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segm…

Drug Manufacturers - Specialty & Generic
US, Bridgewater [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
27.87% YoY
0.00% 3Yr
0.00% 5Yr
0.00% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% 13.18 Yield
96.74% Payout Ratio
Cash Amount Pay Date
Cash Amount Pay Date
End of AMRX's Analysis
CIK: 1723128 CUSIP: 03168L105 ISIN: US03168L1052 LEI: - UEI: -
Secondary Listings
AMRX has no secondary listings inside our databases.